Komm B - Search Results

1

Renal tumors in male rats following long-term administration of bazedoxifene, a tissue-selective estrogen receptor modulator.

Perry R, Thompson CA, Earnhardt JN, Wright DJ, Bailey S, Komm B, Cukierski MA. Perry R, et al. Among authors: komm b. Toxicol Pathol. 2013;41(7):1001-10. doi: 10.1177/0192623313477255. Epub 2013 Feb 15. Toxicol Pathol. 2013. PMID: 23416963

2

Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene.

Wright DJ, Earnhardt JN, Perry R, Bailey S, Komm B, Minck DR, Cukierski MA. Wright DJ, et al. Among authors: komm b. J Cell Physiol. 2013 Apr;228(4):724-33. doi: 10.1002/jcp.24219. J Cell Physiol. 2013. PMID: 22949219

3

Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.

Kulak J Jr, Fischer C, Komm B, Taylor HS. Kulak J Jr, et al. Among authors: komm b. Endocrinology. 2011 Aug;152(8):3226-32. doi: 10.1210/en.2010-1010. Epub 2011 May 17. Endocrinology. 2011. PMID: 21586552 Free PMC article.

4

Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

Mirkin S, Komm BS, Pan K, Chines AA. Mirkin S, et al. Among authors: komm bs. Climacteric. 2013 Jun;16(3):338-46. doi: 10.3109/13697137.2012.717994. Epub 2012 Oct 5. Climacteric. 2013. PMID: 23038989 Clinical Trial.

5

Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.

Komm BS, Thompson JR, Mirkin S. Komm BS, et al. Climacteric. 2015;18(4):503-11. doi: 10.3109/13697137.2014.992011. Epub 2015 Feb 12. Climacteric. 2015. PMID: 25511453 Free article.

6

Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.

Smith CL, Santen RJ, Komm B, Mirkin S. Smith CL, et al. Among authors: komm b. Breast Cancer Res. 2014 Jun 18;16(3):212. doi: 10.1186/bcr3677. Breast Cancer Res. 2014. PMID: 25928299 Free PMC article. Review.

7

Tissue-selective estrogen complexes for postmenopausal women.

Mirkin S, Komm BS. Mirkin S, et al. Maturitas. 2013 Nov;76(3):213-20. doi: 10.1016/j.maturitas.2013.06.003. Epub 2013 Jul 11. Maturitas. 2013. PMID: 23849704 Review.

8

Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.

Mirkin S, Pinkerton JV, Kagan R, Thompson JR, Pan K, Pickar JH, Komm BS, Archer DF. Mirkin S, et al. J Womens Health (Larchmt). 2016 May;25(5):431-42. doi: 10.1089/jwh.2015.5351. Epub 2016 Apr 8. J Womens Health (Larchmt). 2016. PMID: 27058301 Clinical Trial.

9

Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.

Pickar JH, Komm BS. Pickar JH, et al. Post Reprod Health. 2015 Sep;21(3):112-21. doi: 10.1177/2053369115599090. Epub 2015 Aug 19. Post Reprod Health. 2015. PMID: 26289836 Review.

10

Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.

Sakr S, Naqvi H, Komm B, Taylor HS. Sakr S, et al. Among authors: komm b. Endocrinology. 2014 Apr;155(4):1489-97. doi: 10.1210/en.2013-1977. Epub 2014 Jan 31. Endocrinology. 2014. PMID: 24484171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters